tiprankstipranks
Advertisement
Advertisement
Bone Biologics files NELL-1 protein patent application with USPTO
PremiumThe FlyBone Biologics files NELL-1 protein patent application with USPTO
11M ago
Bone Biologics regains compliance with Nasdaq listing
Premium
The Fly
Bone Biologics regains compliance with Nasdaq listing
11M ago
Bone Biologics files $35M mixed securities shelf
Premium
The Fly
Bone Biologics files $35M mixed securities shelf
11M ago
Bone Biologics treated first two patients in study of NB1 bone graft device
PremiumThe FlyBone Biologics treated first two patients in study of NB1 bone graft device
2y ago
Bone Biologics reports progress with NB1 clinical program
Premium
The Fly
Bone Biologics reports progress with NB1 clinical program
2y ago
Bone Biologics files to sell common stock, warrants, no amount given
Premium
The Fly
Bone Biologics files to sell common stock, warrants, no amount given
2y ago
Bone Biologics announces 1-for-8 reverse stock split
PremiumThe FlyBone Biologics announces 1-for-8 reverse stock split
2y ago
Bone Biologics announces closing of registered direct offering
Premium
The Fly
Bone Biologics announces closing of registered direct offering
3y ago
Bone Biologics sells 1.14M shares at 64c in registered direct offering
Premium
The Fly
Bone Biologics sells 1.14M shares at 64c in registered direct offering
3y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100